Inari Medical, Inc. (NARI)
NASDAQ: NARI · IEX Real-Time Price · USD
53.83
-1.37 (-2.48%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Inari Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 520.66 | 493.63 | 383.47 | 276.98 | 139.67 | 51.13 | Upgrade
|
| Revenue Growth (YoY) | 26.10% | 28.73% | 38.45% | 98.31% | 173.17% | 648.70% | Upgrade
|
| Cost of Revenue | 64.22 | 59.07 | 44.51 | 24.76 | 13.11 | 5.91 | Upgrade
|
| Gross Profit | 456.44 | 434.56 | 338.97 | 252.23 | 126.56 | 45.22 | Upgrade
|
| Selling, General & Admin | 368.02 | 350.66 | 292.84 | 189.97 | 89.75 | 37.2 | Upgrade
|
| Research & Development | 92.35 | 87.53 | 74.22 | 51.02 | 18.4 | 7.22 | Upgrade
|
| Depreciation & Amortization | 2.46 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 462.83 | 438.2 | 367.06 | 240.98 | 108.15 | 44.42 | Upgrade
|
| Operating Income | -6.39 | -3.63 | -28.1 | 11.24 | 18.42 | 0.8 | Upgrade
|
| Interest Expense | -0.23 | -0.2 | -0.29 | -0.3 | -1.14 | -0.92 | Upgrade
|
| Interest & Investment Income | 12.66 | 15.61 | 1.85 | 0.15 | 0.48 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.06 | - | 0.36 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | -0.05 | - | -0.02 | -3.98 | -0.84 | Upgrade
|
| EBT Excluding Unusual Items | 5.93 | 11.74 | -26.19 | 11.09 | 13.79 | -0.87 | Upgrade
|
| Merger & Restructuring Charges | -13.18 | -10.4 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.91 | 2.91 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.12 | Upgrade
|
| Other Unusual Items | -6.3 | - | - | -0.4 | - | -0.21 | Upgrade
|
| Pretax Income | -10.65 | 4.25 | -26.19 | 10.69 | 13.79 | -1.19 | Upgrade
|
| Income Tax Expense | 12.97 | 5.88 | 3.08 | 0.85 | - | - | Upgrade
|
| Net Income | -23.62 | -1.64 | -29.27 | 9.84 | 13.79 | -1.19 | Upgrade
|
| Net Income to Common | -23.62 | -1.64 | -29.27 | 9.84 | 13.79 | -1.19 | Upgrade
|
| Net Income Growth | - | - | - | -28.64% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 58 | 57 | 53 | 50 | 32 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 57 | 53 | 56 | 52 | 6 | Upgrade
|
| Shares Change (YoY) | 7.02% | 7.44% | -4.96% | 7.83% | 775.66% | 16.43% | Upgrade
|
| EPS (Basic) | -0.41 | -0.03 | -0.55 | 0.20 | 0.43 | -0.20 | Upgrade
|
| EPS (Diluted) | -0.41 | -0.03 | -0.55 | 0.18 | 0.27 | -0.20 | Upgrade
|
| EPS Growth | - | - | - | -33.33% | - | - | Upgrade
|
| Free Cash Flow | 20.66 | 31.22 | -23.92 | 11.84 | -3.55 | -8.08 | Upgrade
|
| Free Cash Flow Per Share | 0.36 | 0.55 | -0.45 | 0.21 | -0.07 | -1.37 | Upgrade
|
| Gross Margin | 87.67% | 88.03% | 88.39% | 91.06% | 90.62% | 88.44% | Upgrade
|
| Operating Margin | -1.23% | -0.74% | -7.33% | 4.06% | 13.19% | 1.57% | Upgrade
|
| Profit Margin | -4.54% | -0.33% | -7.63% | 3.55% | 9.87% | -2.33% | Upgrade
|
| Free Cash Flow Margin | 3.97% | 6.32% | -6.24% | 4.27% | -2.54% | -15.80% | Upgrade
|
| EBITDA | -0.78 | 1.96 | -23.43 | 14.28 | 19.8 | 1.42 | Upgrade
|
| EBITDA Margin | -0.15% | 0.40% | -6.11% | 5.15% | 14.18% | 2.77% | Upgrade
|
| D&A For EBITDA | 5.61 | 5.59 | 4.67 | 3.03 | 1.39 | 0.61 | Upgrade
|
| EBIT | -6.39 | -3.63 | -28.1 | 11.24 | 18.42 | 0.8 | Upgrade
|
| EBIT Margin | -1.23% | -0.74% | -7.33% | 4.06% | 13.19% | 1.57% | Upgrade
|
| Effective Tax Rate | - | 138.53% | - | 7.91% | - | - | Upgrade
|
| Advertising Expenses | - | 1.2 | 1 | 0.3 | 0.33 | 0.09 | Upgrade
|
Source: S&P Capital IQ. Standard template.